Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07144566 · ClinicalTrials.gov registry record · NA

Improving Sexual Health in Gynecological Cancer Patients

A NA study, sponsored by Cedars-Sinai Medical Center.

Not yet
Registry status
NA
Development phase
35
Enrollment target

NCT07144566: Clinical Trial NA study, sponsored by Cedars-Sinai Medical Center.

NCT07144566 is a NA study that has not yet begun recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07144566, a NA study, has not yet begun recruiting, sponsored by Cedars-Sinai Medical Center.

NOT YET RECRUITING
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

The goal of this clinical trial is to test whether a nurse-led program can improve screening and referral rates for sexual dysfunction and improve sexual health care in individuals with gynecological cancer. The main questions it aims to answer are: Does participation in a nurse-led program improve the treatment of sexual dysfunction in individuals with gynecological cancer? Does the program increase the frequency of screenings and referrals for sexual dysfunction? Participants will: Complete a visit with an advanced practice provider. Fill out the Female Sexual Function Index survey. Allow the research team to review medical records.

Primary Outcome

Assess improvement in sexual dysfunction in gynecologic cancer survivors via the Female Sexual Function Index (FSFI).

Interventions

  • OTHER Nurse Led Sexual Health Clinical Program Intervention

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2025-09-02
Est. Completion 2026-04-30
Phase NA
Cedars-Sinai Medical Center

339 total trials

What is known before NCT07144566 opens enrollment

NCT07144566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Nurse Led Sexual Health Clinical Program Intervention is the first listed.

NCT07144566 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07144566 about?

NCT07144566 is a clinical study titled "Improving Sexual Health in Gynecological Cancer Patients". The goal of this clinical trial is to test whether a nurse-led program can improve screening and referral rates for sexual dysfunction and improve sexual health care in individuals with gynecological cancer. The main questions it aims to answer are: Does participation in a nurse-led program improve...

What is the current status of trial NCT07144566?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-09-02. Estimated completion is 2026-04-30.

What interventions are being tested in trial NCT07144566?

The interventions under investigation include: Nurse Led Sexual Health Clinical Program Intervention (OTHER).

Who is sponsoring clinical trial NCT07144566?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07144566's enrollment target sits among peer trials

35 1564th of 2000 higher than 431 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07144566, the US trial registry maintained by the National Library of Medicine. NCT07144566 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.